Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Jun 1;144:109911. doi: 10.1016/j.mehy.2020.109911

Fighting against frailty and sarcopenia – As well as COVID-19?

Timur Ekiz a,, Murat Kara b, Levent Özçakar b
PMCID: PMC7263226  PMID: 32505075

Geriatric syndromes, including sarcopenia and frailty, are necessarily on the agenda - as the mortality rate of COVID-19 is higher in the elderly [1]. Herein, sarcopenia is defined as age-related loss of muscle mass and function, and frailty as multi-system impairment related with increased vulnerability to stressors [2]. Of note, sarcopenia is an essential component of physical frailty; therefore they are like the two sides of the same coin [2]. Both are associated with hospitalization, increased disability, and even mortality. Yet, frail patients are at increased risk of infectious diseases due to the increased inflammatory condition and significant immune system changes e.g. impaired proliferation of peripheral mononuclear cells and upregulated monocyte expression [3]. Likewise, the cytokine storm in COVID-19 patients is known to have poor prognosis due to the increased inflammatory response [4].

In short, we simply underscore that preventive measures for frailty/sarcopenia i.e. exercise, nutrition and vitamin (D) supplementation can fortify the fight against COVID-19 as well [5].

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  • 1.Koff W.C., Williams M.A. Covid-19 and immunity in aging populations - a new research agenda. N Engl J Med. 2020 doi: 10.1056/NEJMp2006761. in press. [DOI] [PubMed] [Google Scholar]
  • 2.Cesari M., Landi F., Vellas B., Bernabei R., Marzetti E. Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. 2014;28(6):192. doi: 10.3389/fnagi.2014.00192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Yao X., Li H., Leng S.X. Inflammation and immune system alterations in frailty. Clin Geriatr Med. 2011;27(1):79–87. doi: 10.1016/j.cger.2010.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mehta P., McAuley D.F., Brown M. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S0140-6736(20)30628-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kara M., Ata A.M., Kaymak B., Özçakar L. Ultrasound imaging and rehabilitation of muscle disorders part 2. Non-traumatic conditions. Am J Phys Med Rehabil. 2020 doi: 10.1097/PHM.0000000000001352. In Press. [DOI] [PubMed] [Google Scholar]

Articles from Medical Hypotheses are provided here courtesy of Elsevier

RESOURCES